Private company

Dermira (United States)

Dermira (United States) is an American pharmaceutical preparations company based in Menlo Park.1 It was founded in 2011.1

Last updated Oct 20, 2026.

Overview

2011Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersMenlo Park1
  • Websitedermira.com
  • Incorporated inDE3
  • Business address275 Middlefield Road, Suite 150, Menlo Park, Ca 940253
  • Filer categoryAccelerated filer3

See how the biggest companies compare on our leaderboards

What it owns

What Dermira (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$2.2M4 Dec 31, 2018$1.9M4 Dec 31, 2017+13.0%
Accumulated depreciation$1.0M4 Dec 31, 2018$511.0K4 Dec 31, 2017+99.0%
Property and equipment, net$1.2M4 Dec 31, 2018$1.4M4 Dec 31, 2017−17.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$105.0M4 Dec 31, 2018$295.9M4 Dec 31, 2017−64.5%
Marketable securities, current$208.1M4 Dec 31, 2018$255.1M4 Dec 31, 2017−18.4%
Marketable securities, non-current$3.0M4 Dec 31, 2018$24.6M5 Dec 31, 2016−87.9%
Debt securities available for sale$308.3M4 Dec 31, 2018$548.5M4 Dec 31, 2017−43.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$771.0K4 Dec 31, 2018$771.0K4 Dec 31, 20170%
Indefinite-lived intangibles (excluding goodwill)$952.0K4 Dec 31, 2018$1.1M4 Dec 31, 2017−15.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$8.4M4 Dec 31, 2018
Raw materials$4.1M4 Dec 31, 2018
Work in process$1.0M4 Dec 31, 2018
Finished goods$3.2M4 Dec 31, 2018

Leadership

Who has led Dermira (United States), and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Thomas G. Wiggans2014–2020

Chair

  1. Thomas G. Wiggans2014–2020

Chief financial officer

  1. Andrew Guggenhime2014–2020

Chief operating officer

  1. Andrew Guggenhime2014–2018
201520202025
Board members and other officers (15)

Timeline

  1. Oct 2, 2014New chief executive Thomas G. Wiggans becomes CEO6
  2. 2011Founded Founded1

SEC filer profile

How Dermira (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARDermira, Inc.2
  • CIK0001557883
  • Employer ID (EIN)27-32676802
  • Filer statusAccelerated filer2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address275 Middlefield Road, Suite 150, Menlo Park, CA 940252
  • Phone650 421 72002
  • Shares outstanding54,521,180 as of Oct 31, 201922
  • Public float$318.3M as of Jun 29, 20184
  • On EDGAR sinceSep 12, 20122
  • Filings501 in all: 4 (246), 8-K (59), 3 (32), SC 13G/A (25), 10-Q (16), SC 13G (13), CORRESP (9), SC 13D/A (9)2
    All 46 form types

    424B5 (7), D (6), S-8 (6), S-8 POS (6), 10-K (5), DEF 14A (5), EFFECT (5), S-1/A (5), SC 13D (5), UPLOAD (5), CT ORDER (3), SC 14D9/A (3), 4/A (2), 424B4 (2), S-1 (2), S-3 (2), SC TO-T/A (2), 15-12B (1), 25-NSE (1), 5 (1), 8-A12B (1), 8-K/A (1), ARS (1), CERTNAS (1), DEFA14A (1), DRS (1), DRS/A (1), DRSLTR (1), POS AM (1), POS EX (1), POSASR (1), S-1MEF (1), S-3/A (1), S-3ASR (1), SC 14D9 (1), SC TO-C (1), SC TO-T (1), SC14D9C (1)

  • Latest filingsAnnual report (10-K) Feb 26, 2019
    Quarterly report (10-Q) Nov 5, 2019
    Proxy statement (DEF 14A) Apr 24, 2019
    Latest 8-K (8-K) Feb 20, 2020

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22